Who we are

PharmaLex Belgium provides statistical expertise through consulting services, training and dedicated software to pharmaceutical and biopharmaceutical companies. Our goal is the same as the companies we support – to efficiently and consistently develop and deliver quality medicine to patients.

What makes us different?

Leveraging statistics is more than just applying statistical methods

  • We understand the entire product lifecycle, and provide holistic solutions focused on the patient
  • We ask questions so that we can use the right statistics to solve the right business problem. We apply “fit for purpose” statistics with the business problem in mind, considering simplicity, accuracy, and risk
  • We understand the science of your business. We have diverse backgrounds including biology, engineering, computing, and chemistry
  • We understand the regulatory environment: GxP, ICH, GAMP, FDA, EMEA, and have a full quality system
  • We are recognized experts in applying Bayesian methods to accelerate development , reduce resources, and manage risk
  • Today, as the PharmaLex network continues to grow, we are poised to deliver paradigm-changing solutions in a highly regulated environment that transcend geographies and specialisms, fulfilling the needs of an extended global client base.
  • Our strength and competencies stem from the multidisciplinary background of our team.
  • We draw from the combined knowledge of the whole spectrum of life sciences (including biology, biochemistry, pharmacology, engineering, food chemistry, medicine, nutritional science, pharmacy science, toxicology and veterinary medicine).
  • Our experts have many years of experience.

Local Contact

  • Francois De Witte
    Chief Financial Officer PharmaLex Belgium Rue Edouard Belin, 5
    1435 Mont-St-Guibert
    Belgium
    +32 10 46 10 10

    PharmaLex Belgium has a Data Protection Officer who can be contacted on dpo-plxstat@pharmalex.com

What our clients say about us

We are working with a number of large pharma companies and are looking to create a consortium of partners to collect feedback on expertise, availability and outcomes. If you would be interested in joining our consortium, please contact us on contact@pharmalex.com.

  • Thanks so much for your support over the past 30 days. Your commitment and timely communication have made working with you all a pleasant experience.

    US Biotech
    Senior QA Associate
  • I just wanted to let you know that the recent EU Codes webinar was excellent. Rina presented a very complex and grey topic in the most clear and digestible manner – a sign of a true expert. The questions in the Q&A were sometimes a little ambiguous but Rina gave clear and relevant answers that provided real clarity.

    Richard Blackwell
    Medical Team Leader, Multi Tumor Franchise Roche Products Ltd
  • We really appreciate your responsiveness and availability during our previous exchanges and it is what we are waiting for from our partner.

    Small Medium Sized Company, UK
    Head of Regulatory Affairs
  • During the bid defense we felt that you worked well as team and are very dynamic. Preparation of such a complex dossier really needs to be done in such a way.

    Large Pharma, Germany
    VP Regulatory Affairs